Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MASS | US
-0.02
-0.30%
Healthcare
Medical Devices
30/06/2024
24/04/2026
6.74
6.80
7.06
6.68
908 Devices Inc. a commercial-stage technology company provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research bioprocessing industrial biotech forensics and adjacent markets. The company's products include MX908 a handheld battery-powered and Mass Spec device that is designed for rapid analysis of gas liquid and solid materials of unknown identity; Rebel a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; Maven and Trace C2 an online device for bioprocess monitoring and control; and ZipChip solution a plug-and-play high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas Europe the Middle East Africa and the Asia Pacific. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston Massachusetts.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
37.9%1 month
50.8%3 months
50.3%6 months
62.0%-
-
0.78
0.04
0.03
-3.15
0.96
-
-42.30M
233.59M
233.59M
-
-96.53
-
16.10
-22.96
7.45
6.21
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.12
Range1M
2.02
Range3M
2.20
Rel. volume
0.53
Price X volume
855.27K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Ekso Bionics Holdings Inc | EKSO | Medical Instruments & Supplies | 10.99 | 236.77M | 1.48% | n/a | 55.49% |
| Outset Medical Inc | OM | Medical Devices | 4.52 | 235.45M | -1.09% | n/a | 294.91% |
| Utah Medical Products Inc | UTMD | Medical Instruments & Supplies | 67.17 | 233.56M | -1.03% | 15.31 | 0.22% |
| enVVeno Medical Corporation | NVNO | Medical Devices | 13 | 227.97M | 0.39% | n/a | 3.21% |
| OraSure Technologies Inc | OSUR | Medical Instruments & Supplies | 3 | 223.70M | -1.64% | 11.53 | 2.96% |
| Electromed Inc | ELMD | Medical Devices | 26.39 | 221.80M | 3.57% | 39.79 | 0.20% |
| InfuSystem Holdings Inc | INFU | Medical Instruments & Supplies | 10.34 | 220.40M | 0.68% | 702.00 | 73.21% |
| Sight Sciences Inc. | SGHT | Medical Devices | 4.36 | 219.34M | 0.93% | n/a | 34.46% |
| KRMD | KRMD | Medical Instruments & Supplies | 3.96 | 181.59M | -0.75% | n/a | 21.21% |
| Pro-Dex Inc | PDEX | Medical Instruments & Supplies | 52.1 | 173.12M | 2.24% | 44.92 | 43.89% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| RE/MAX Holdings Inc | RMAX | Real Estate Services | 7.99 | 251.02M | 21.80% | n/a | 114.28% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 18.17 | 202.74M | 2.83% | 15.61 | -621.78% |
| Douglas Elliman Inc. | DOUG | Real Estate Services | 1.96 | 179.99M | 4.81% | n/a | 62.82% |
| Comstock Holding Companies Inc | CHCI | Real Estate Services | 17.05 | 168.14M | -2.46% | 14.10 | 17.12% |
| STHO | STHO | Real Estate Services | 8.3 | 110.55M | -0.48% | n/a | 59.21% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 36.11 | 103.70M | 0.00% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.11 | 99.53M | 1.16% | 9.09 | 39.79% |
| The InterGroup Corporation | INTG | Real Estate Services | 36.58 | 79.71M | 3.66% | n/a | -238.17% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.765 | 73.67M | 1.69% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.9 | 70.43M | 6.56% | n/a | 5.48% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.15 | 46.09 | Cheaper |
| Ent. to Revenue | 0.96 | 14.34 | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 0.78 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 50.34 | 64.12 | Lower Risk |
| Debt to Equity | 0.04 | -145.53 | Expensive |
| Debt to Assets | 0.03 | 0.35 | Cheaper |
| Market Cap | 233.59M | 9.70B | Emerging |